BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ChemCon GmbH Receives Approval To Manufacture Semi-Solid Pharmaceuticals For Human Use


12/3/2013 9:20:43 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Freiburg /Germany / 03. Dec. 2013 - Following a successful inspection by the German health authorities in July 2013 ChemCon received the approval required to manufacture semi-solid pharmaceuticals (gels and creams for topical therapy) for human use. This was an important step for the expansion of ChemCon’s service portfolio and will allow us to reach new customer groups.

ChemCon is now able to offer services along the entire development chain for pharmaceutical products. This includes the early R&D stages of drug development, the transfer of the manufacturing process to production under GMP conditions and the production of drug product samples for clinical trials. Both the placebo and active treatment arms of clinical trials are covered by this approval. We can save our customers time and money by aiding them during all the interlinked development phases required for new pharmaceutical products.

A recent project involved the production of both the placebo and the active ingredient for phase II clinical trials. First, the manufacturing of the API und GMP conditions was completed, followed by creation of both placebo and API containing gel samples. These samples were randomized by ChemCon and delivered to the clinical trials center. The API was based upon a tellurium complex which possesses anti-viral properties, especially against papillomaviruses. This was one of the first tellurium complexes used medically and represented pioneering work by ChemCon.

About ChemCon:

ChemCon GmbH is a leading global supplier of high-quality active pharmaceutical ingredients (API) and fine chemicals, located in Freiburg, Germany. The company is specialized on small molecule chemistry – organic and inorganic. Based around chemical development on various stages of drug development ChemCon offers an all-in-one-hand service including full analytical support, complete documentation and outstanding quality management. Learn more about the company at www.chemcon.com.

Contact:

Tobias Timtner Tel.: +49 761-5597-310

Marketing Manager Fax: +49 761-5597-449

ChemCon GmbH E-Mail: tobias.timtner@chemcon.com

Engesserstr. 4b

79108 Freiburg

Germany

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES